Skip to main content
SpringerLink
Log in
Book cover

Inscription, Diagnosis, Deception and the Mental Health Industry pp 81–106Cite as

Palgrave Macmillan

The Oblivion Express: Big Pharma

  • Chapter

  • 351 Accesses

Abstract

“Patients and their families need to know that psychiatry is an uncertain branch of medicine, that well-qualified psychiatrists frequently disagree, that they deal more in judgement calls than in answers, and that the risk of a bad outcome is sometimes high.”1

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

  1. Kelley, J.L. (1996) Psychiatric Malpractice. Stories of Patients, Psychiatrists and the Law. New Brunswick, NJ: Rutgers University Press.

    Google Scholar 

  2. Chadwick, P. (2014) How do creative artists cope on The Edge? Journal of Critical Psychology, Counselling and Psychotherapy, 14, 2, 70–74.

    Google Scholar 

  3. Newnes, C. (2007) Frank Zappa (21 December 1940–4 December 1993) Journal of Critical Psychology, Counselling and Psychotherapy, 7, 2, 121.

    Google Scholar 

  4. Camus, A. (1942) Le Mythe de Sisyphe. Paris: Gallimard.

    Google Scholar 

  5. Engels, F. (2012) The Condition of the Working Class in England. Oxford: Oxford University Press.

    Google Scholar 

  6. Szasz, T. (1987) Insanity: The Idea and Its Consequences. New York: Wiley.

    Google Scholar 

  7. Perry, K. (2014) Stress can be transmitted through TV screen. Daily Telegraph, 2 May, p.16.

    Google Scholar 

  8. BMA/RPSGB (1999) British National Formulary, September. Wallingford: Pharmaceutical Press, p.186.

    Google Scholar 

  9. Stimmel, B. (1983) Pain, Analgesia and Addiction. New York: Raven Press.

    Google Scholar 

  10. Gabe, J. (ed.) (1991) Understanding Tranquilliser Use: The Role of the Social Sciences. London: Routledge, p.2.

    Google Scholar 

  11. Olivieri, S., Cantopher, T. and Edwards, J.G. (1986) Two hundred years of dependence on antianxiety drugs. Human Psychopharmacology, 1, 117–23.

    Article  Google Scholar 

  12. Parish, P. (1971) The prescribing of psychotropic drugs in general practice. Journal of the Royal College of General Practitioners, 21, Suppl. 4, 1–77.

    Google Scholar 

  13. Goldacre, B. (2012) Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients. London: HarperCollins.

    Google Scholar 

  14. Braithwaite, J. (1984) Corporate Crime in the Pharmaceutical Industry. London: Routledge, Kegan & Paul.

    Google Scholar 

  15. Timimi, S. and Radcliffe, N. (2005) The rise and rise of ADHD. In C. Newnes and N. Radcliffe (eds), Making and Breaking Children’s Lives. Ross-on-Wye: PCCS Books, pp.63–70.

    Google Scholar 

  16. Newnes, C. and Radcliffe, N. (2005) The Destruction of children. In C. Newnes and N. Radcliffe (eds), Making and Breaking Children’s Lives. Ross-on-Wye: PCCS Books. pp.iii-vi.

    Google Scholar 

  17. Szasz, T.S. (1961) The myth of mental illness. American Psychologist, 15, 113–118.

    Article  Google Scholar 

  18. Newnes, C. and Holmes, G. (1996) Medication: The holy water of psychiatry. Openmind, 82, 14–15.

    Google Scholar 

  19. Busfield, J. (2013) The Pharmaceutical Industry and Mental Disorder. Ross-on-Wye: PCCS Books.

    Google Scholar 

  20. NHS Centre for Reviews and Dissemination. (1999) Drug treatment for schizophrenia. Effective Health Care, 5, 6, 1–12.

    Google Scholar 

  21. Busfield, J. (2010). A pill for every ill. Explaining the expansion in medicine use. Social Science and Medicine, 70, 934–941.

    Article  Google Scholar 

  22. Healy, D. (2013) Pharmageddon. Berkley: University of California Press.

    Google Scholar 

  23. French, J.R.P. and Raven, B. (1959) The bases of social power. In D. Cartwright and A. Zander (eds), Group Dynamics. New York: Harper & Row, pp.150–167.

    Google Scholar 

  24. Moncrieff, J. (2007). The Myth of the Chemical Cure: A critique of psychiatric drug treatment. Basingstoke: Palgrave MacMillan.

    Book  Google Scholar 

  25. Clifton, J.W. (2002) States of mind. Clinical Psychology, 18, 52.

    Google Scholar 

  26. Leo, J. and Lacasse, J. (2009) Clinical trials of therapy versus medication: Even in a tie, medication wins. British Medical Journal, 338, 463.

    Article  Google Scholar 

  27. Healy, D. (2008) Academic stalking and brand fascism. In J. Turk J and J. Thompson (eds), Universities at Risk: How Politics, Special Interests and Corporatization Threaten Academic Integrity. Toronto: Lorimer Press, pp.108–137.

    Google Scholar 

  28. Rosenthal R. (1979) The “file drawer problem” and tolerance for null results. Psychological Bulletin, 86, 638–641.

    Article  Google Scholar 

  29. Deyo, R.A., Psaty, B.M., Simon, G., Wagner, E.H. and Omenn, G.S. (1997) The messenger under attack — Intimidation of researchers by special-interest groups. New England Journal of Medicine, 336, 1176–1179.

    Article  Google Scholar 

  30. Healy, D. (2002) Conflicting interests in Toronto: Anatomy of a controversy at the interface of academia and industry. Perspectives in Biology and Medicine, 45, 250–263.

    Article  Google Scholar 

  31. Siebert, A. (1999) Brain disease hypothesis for schizophrenia disconfirmed by all evidence. Ethical Human Sciences and Services, 1, 2, 179–189.

    Google Scholar 

  32. Pam, A. (1990) A critique of the scientific status of biological psychiatry. Acta Psychiatrica Scandinavica, 82, Suppl. 362, pp.1–35.

    Article  Google Scholar 

  33. Ross, C.A. and Pam, A. (1995) Pseudoscience in Biological Psychiatry: Blaming the Body. Chichester: John Wiley & Sons.

    Google Scholar 

  34. Leo, J. and Cohen, D. (2003) Broken brains or flawed studies? A critical review of ADHD neuroimaging research. The Journal of Mind and Behavior, 24, 1, 29–56.

    Google Scholar 

  35. WHO (1992) Schizophrenia: Manifestations, incidence and course in different cultures: A World Health Organization ten-country study. Psychological Medicine, Suppl. 20, 1–95.

    Google Scholar 

  36. Cohen, D. (1997) A critique of the use of neuroleptic drugs. In S. Fisher and R. Greenburg (eds), From Placebo to Panacea. Chichester: John Wiley & Sons, pp.173–228

    Google Scholar 

  37. Lehmann, P. (2010) Medicalization and irresponsibility. Journal of Critical Psychology, Counselling and Psychotherapy, 10, 4, 209–218.

    Google Scholar 

  38. Stip, E. (2002) Happy birthday neuroleptics! 50 year later: la folie du doute, European Psychiatry, 17, 1–5.

    Article  Google Scholar 

  39. Geddes, J., Freemantle, N., Harrison, P. and Bebbington, P. (2000) Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis British Medical Journal, 2, 321, 7273, 1371–1376.

    Article  Google Scholar 

  40. Harding, C. (1994) Empirical correction of seven myths about schizophrenia with implications for treatment. ACTA Psyciatrica Scandinavica, 90, Suppl. 384, 140–146.

    Article  Google Scholar 

  41. Jackson, S.W. (1986) Melancholia and Depression. New Haven, CT: Yale University Press.

    Google Scholar 

  42. Bassuk, E.L. and Schoonover, S.C. (1977) The Practitioner’s Guide to Psychoactive Drugs. New York: Plenum.

    Book  Google Scholar 

  43. McMahon, T.C. (1986) A clinical overview of syndromes following withdrawal from antidepressants. Hospital and Community Psychiatry, 37, 883–884.

    Google Scholar 

  44. Webb, D. (2013) Thinking About Suicide: Contemplating and Comprehending the Urge to Die. Ross-on-Wye: PCCS Books.

    Google Scholar 

  45. Caplan, R.D., Andrews, F.M., Conway, T.L., Abbey, A., Abramis, D.J. and French, J.R.P. (1985) Social effects of diazepam use: A longitudinal field study. Social Science and Medicine, 21, 887–98.

    Article  Google Scholar 

  46. Williams, P. (1983) Factors effecting the duration of treatment with psychotropic drugs in general practice: A survival analysis approach. Psychological Medicine, 13, 623–33.

    Article  Google Scholar 

  47. Wolfensberger, W. (1987) The New Genocide of Handicapped and Afflicted People. New York: University of Syracuse.

    Google Scholar 

Download references

Authors
  1. Craig Newnes
    View author publications

    You can also search for this author in PubMed Google Scholar

Copyright information

© 2016 Craig Newnes

About this chapter

Cite this chapter

Newnes, C. (2016). The Oblivion Express: Big Pharma. In: Inscription, Diagnosis, Deception and the Mental Health Industry. Palgrave Macmillan, London. https://doi.org/10.1057/9781137312969_7

Download citation

  • DOI: https://doi.org/10.1057/9781137312969_7

  • Publisher Name: Palgrave Macmillan, London

  • Print ISBN: 978-0-230-29366-3

  • Online ISBN: 978-1-137-31296-9

  • eBook Packages: Social SciencesSocial Sciences (R0)

Publish with us

Policies and ethics

Search

Navigation